68Ga-FAPI与18F-FDG PET/CT在IgG4相关性疾病评估中的互补作用:系统综述与汇总分析
该系统综述汇总3项高质量头对头研究(n=90),比较68Ga-FAPI与18F-FDG PET/CT在IgG4相关性疾病中的诊断与分期价值。68Ga-FAPI在实质器官(胰腺、唾液腺)的SUVmax和靶本比显著高于18F-FDG(P<0.001),且检出病灶总数更多(136 vs. 78);FDG更易显示淋巴结活性。病理提示FAPI与纤维化相关、FDG与炎症相关,形成「flip-flop」模式,FAPI/FDG比值≥1.5可预测复发风险。
要点
- 68Ga-FAPI在胰腺、唾液腺等实质器官的SUVmax和靶本比显著高于18F-FDG(P<0.001)。
- 68Ga-FAPI检出病灶总数136个,多于18F-FDG的78个,更利于评估全身负荷。
- FAPI/FDG比值≥1.5可预测复发风险,双示踪剂联合可评估纤维炎性活动。
核心结论
- 68Ga-FAPI在实质器官受累评估中优于18F-FDG,而FDG更突出炎症性淋巴结病变,二者联合可实现纤维炎性活动的多模态评估并指导个体化管理与预后判断。
研究设计与样本
- 系统综述与汇总分析,纳入3项高质量头对头研究,共90例IgG4相关性疾病患者。
主要发现
- 68Ga-FAPI在胰腺、唾液腺等实质器官的SUVmax和靶本比显著高于18F-FDG(P<0.001),病灶对比度更优。
- 18F-FDG检测到更多淋巴结活性,而68Ga-FAPI检出病灶总数136个,18F-FDG为78个,FAPI改善全身负荷评估。
- 病理显示FAPI与纤维化相关、FDG与炎症相关,形成「flip-flop」模式。
- FAPI/FDG比值≥1.5可预测复发风险。
关键数值与推荐
- 68Ga-FAPI在实质器官的SUVmax和靶本比显著高于18F-FDG(P<0.001)。
- 68Ga-FAPI检出病灶总数136个,18F-FDG检出78个。
- FAPI/FDG比值≥1.5预测复发风险。
临床怎么用
- 对IgG4相关性疾病患者可联合68Ga-FAPI与18F-FDG PET/CT,分别评估纤维化与炎症活动。
- 实质器官受累优先关注68Ga-FAPI显像,淋巴结活动可参考18F-FDG显像。
- 可利用FAPI/FDG比值≥1.5识别复发风险较高的患者。
局限性
- 汇总分析仅纳入3项研究、共90例患者,样本量有限。
- 原文未报告标准化影像诊断标准的具体条款。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: IgG4-related disease (IgG4-RD) lacks standardized imaging criteria. This study systematically reviewed head-to-head comparisons of 68Ga-FAPI and 18F-FDG PET/CT to clarify their complementary roles in diagnosing and staging IgG4-RD. MAIN BODY: Three high-quality studies (n = 90) were pooled. 68Ga-FAPI showed significantly higher SUVmax and target-to-background ratios (TBR) in parenchymal organs (pancreas, salivary glands) vs. 18F-FDG (P < 0.001), offering superior lesion contrast. While 18F-FDG detected more lymph node activity, 68Ga-FAPI identified 136 vs. 78 total lesions, improving systemic burden assessment. Pathology correlated FAPI with fibrosis and FDG with inflammation, defining a "flip-flop" pattern. A FAPI/FDG ratio ≥ 1.5 predicted relapse risk. CONCLUSION: 68Ga-FAPI excels in parenchymal organ involvement, while FDG highlights inflammatory lymphadenopathy. Combining both tracers enables multimodal evaluation of fibroinflammatory activity, guiding personalized management and prognostication in IgG4-RD.
引用
- Cai X, Wang Q, Hao Q, et al. Complementary roles of 68Ga-FAPI and 18 F-FDG PET/CT in evaluating IgG4-related disease: a systematic review and pooled analysis. EJNMMI Res. 2026. PMID: 42268509. doi:10.1186/s13550-026-01452-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。